We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life

News

Abiogen Pharma Completes the Acquisition of Effrx

Our Products

The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.

Partnering with us

Our strategy relies on partnerships for shared commercial success.
Scroll to Top